Regua AT, Bindal S, Najjar MK, Zhuang C, et al. Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers. Cancer Lett 2024;597:217023.
PMID: 38852701